RecruitingNCT04821154

Persona Revision Knee System Outcomes

Clinical Investigation to Demonstrate Performance, Safety and Clinical Benefits of the Persona Revision Knee System


Sponsor

Zimmer Biomet

Enrollment

380 participants

Start Date

Jun 14, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. This will be done using a multicenter, single-arm, consecutive series, retrospective cohort study with prospective follow-up.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • Male or female of at least 18 years of age at the time of screening.
  • Signed an institutional review board approved informed consent.
  • Willingness and ability to comply with the study procedures and visit schedules and ability to understand and follow oral and written post-operative care instructions.
  • Previous medical diagnosis/ history of at least one of the following conditions requiring treatment using the Persona Revision Knee System within a pre-specified study variant configuration (cohort), in accordance with the instructions for use (IFU):
  • Rheumatoid arthritis, osteoarthritis, traumatic arthritis or polyarthritis
  • Collagen disorders, and/or avascular necrosis of the femoral condyle
  • Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
  • Moderate valgus, varus, or flexion deformities
  • The salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery
  • A pre-operative Knee Society Knee Score (objective assessment) ≤ 80.

Exclusion Criteria14

  • \) Presence of clinically observed active or suspected latent infection in the affected joint at the time of procedure.
  • \) Presence of of local/systemic/distant focal infection that may affect or hematogenously spread to the prosthetic joint.
  • \) Skeletal immaturity or insufficient bone stock on femoral or tibial surfaces which cannot provide adequate support and/or fixation to the prosthesis.
  • \) Diagnosed with neuropathic arthropathy, osteoporosis, or any loss of musculature or neuromuscular disease that compromises the affected limb.
  • \) Presence of a stable, painless arthrodesis in a satisfactory functional position in the affected joint.
  • \) Severe instability of the affected joint secondary to the absence of collateral ligament integrity.
  • \) Diagnosis of rheumatoid arthritis in conjunction with any of the following at the time of screening:
  • An ulcer of the skin
  • History of recurrent breakdown of the skin
  • Use of steroids
  • \) Patient requires simultaneous bilateral knee surgery for treatment of diagnosed condition.
  • \) Pregnant or women planning to become pregnant during the time they will be participating in the study.
  • \) Any documented clinically significant degree of cognitive impairment or other condition, finding, or psychiatric illness at screening which, in the opinion of the Investigator, could compromise patient safety or interfere with the assessment of the safety and treatment effects of the study procedure.
  • \) Any patient who is institutionalized, or with a known drug or alcohol dependence currently or within the last year.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPersona Revision Knee System

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.


Locations(16)

Advanced Orthopaedic Specialists

Fayetteville, Arkansas, United States

Bowen Hefley Orthopedics

Little Rock, Arkansas, United States

Community Foundation Medical Group

Fresno, California, United States

Cornerstone Orthopaedics & Sports Medicine

Superior, Colorado, United States

Orthopaedic Associates, Inc.

Evansville, Indiana, United States

Jeff Yergler, LLC

Granger, Indiana, United States

Arthroplasty Foundation Inc.

Louisville, Kentucky, United States

Ascension Providence Rochester Hospital

Rochester, Michigan, United States

Michigan Orthopaedic Surgeons, PLLC

Southfield, Michigan, United States

TRIA Orthopaedic Center Research Institute

Bloomington, Minnesota, United States

Thomas Aleto MD, PC

Columbia, Missouri, United States

Orthopaedic Research Institute of New Jersey

Chester, New Jersey, United States

The Cleveland Clinic Foundation

Cleveland, Ohio, United States

ROC Orthopedics

Oregon City, Oregon, United States

Penn Medicine/ Lancaster General Health

Lancaster, Pennsylvania, United States

Orthopedic Surgeons of Wisconsin, SC

Wauwatosa, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04821154


Related Trials